The current valuation score of BioRestorative Therapies Inc is 6.08, ranking 361 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.38, which is -7366.84% below the recent high of 27.27 and -577.40% above the recent low of -2.54.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.